Total Payments
$15,864
2024 Payments
$298.07
Companies
33
Transactions
305
Medicare Patients
3,638
Medicare Billing
$781,126
Payment Breakdown by Category
Other$9,170 (57.8%)
Food & Beverage$6,094 (38.4%)
Consulting$600.00 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,170 | 8 | 57.8% |
| Food and Beverage | $6,094 | 296 | 38.4% |
| Consulting Fee | $600.00 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,728 | 50 | $0 (2024) |
| RedHill Biopharma Inc. | $4,567 | 23 | $0 (2024) |
| Allergan Inc. | $2,251 | 21 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $782.47 | 53 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $704.57 | 36 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $682.11 | 21 | $0 (2023) |
| Gilead Sciences, Inc. | $304.57 | 17 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $231.59 | 13 | $0 (2017) |
| Janssen Biotech, Inc. | $149.52 | 6 | $0 (2023) |
| Madrigal Pharmaceuticals | $137.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $298.07 | 10 | Madrigal Pharmaceuticals ($137.09) |
| 2023 | $2,838 | 19 | ABBVIE INC. ($2,558) |
| 2022 | $1,109 | 40 | Ironwood Pharmaceuticals, Inc ($264.10) |
| 2021 | $3,793 | 60 | AbbVie Inc. ($1,777) |
| 2020 | $3,579 | 39 | RedHill Biopharma Inc. ($2,996) |
| 2019 | $1,106 | 46 | Allergan Inc. ($302.06) |
| 2018 | $490.45 | 35 | Takeda Pharmaceuticals U.S.A., Inc. ($277.64) |
| 2017 | $2,650 | 56 | Allergan Inc. ($1,887) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $137.09 | General |
| Category: LIVER DISEASE | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Gastroenterology | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/05/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2024 | RedHill Biopharma Inc. | Talicia (Drug), Aemcolo | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| Category: Antibiotic | ||||||
| 02/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2023 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Antibiotic | ||||||
| 08/15/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/07/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Immunology | ||||||
| 07/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/20/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $10.30 | General |
| Category: GI | ||||||
| 07/20/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $2.92 | General |
| Category: GI | ||||||
| 07/12/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: GI | ||||||
| 05/25/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: GI | ||||||
| 03/30/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: Immunology | ||||||
| 03/28/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/09/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 881 | 1,031 | $560,300 | $184,977 |
| 2022 | 10 | 992 | 1,191 | $665,050 | $223,473 |
| 2021 | 10 | 956 | 1,098 | $602,750 | $212,184 |
| 2020 | 9 | 809 | 937 | $498,100 | $160,492 |
Total Patients
3,638
Total Services
4,257
Medicare Billing
$781,126
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 146 | 156 | $171,400 | $53,841 | 31.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 105 | 107 | $149,800 | $44,238 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 339 | 476 | $71,700 | $33,821 | 47.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 46 | 46 | $55,200 | $17,908 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 162 | 162 | $40,600 | $15,222 | 37.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 24 | 24 | $28,800 | $9,336 | 32.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 28 | 28 | $36,400 | $7,230 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 32 | $6,400 | $3,381 | 52.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 190 | 205 | $225,500 | $74,735 | 33.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 123 | 125 | $175,000 | $53,727 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 353 | 535 | $80,250 | $38,269 | 47.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 180 | 180 | $45,000 | $16,413 | 36.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 31 | 31 | $37,200 | $12,748 | 34.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 36 | 36 | $46,800 | $8,769 | 18.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 21 | 21 | $25,200 | $8,548 | 33.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 17 | 17 | $20,400 | $5,270 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 26 | $5,200 | $2,818 | 54.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,500 | $2,176 | 48.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 180 | 184 | $202,400 | $69,067 | 34.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 103 | 105 | $147,000 | $46,442 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 356 | 490 | $73,500 | $37,653 | 51.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2021 | 44 | 44 | $52,800 | $18,321 | 34.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 159 | 159 | $39,750 | $16,101 | 40.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2021 | 21 | 21 | $25,200 | $8,687 | 34.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 25 | 26 | $33,800 | $4,629 | 13.7% |
About Dr. Gary Gorodokin, MD
Dr. Gary Gorodokin, MD is a Gastroenterology healthcare provider based in Fair Lawn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619996774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Gorodokin, MD has received a total of $15,864 in payments from pharmaceutical and medical device companies, with $298.07 received in 2024. These payments were reported across 305 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,170).
As a Medicare-enrolled provider, Gorodokin has provided services to 3,638 Medicare beneficiaries, totaling 4,257 services with total Medicare billing of $781,126. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Fair Lawn, NJ
- Active Since 07/19/2006
- Last Updated 03/15/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619996774
Products in Payments
- Talicia (Drug) $3,888
- LINZESS (Drug) $2,487
- CREON (Drug) $998.67
- Linzess (Drug) $636.51
- Amitiza (Drug) $448.58
- TRULANCE (Drug) $397.89
- XIFAXAN (Drug) $273.91
- ZEPOSIA (Drug) $166.64
- MOTEGRITY (Drug) $163.60
- Dexilant (Drug) $161.07
- VIBERZI (Drug) $144.85
- REZDIFFRA (Drug) $137.09
- STELARA (Biological) $135.90
- Mulpleta (Drug) $135.87
- FARXIGA (Drug) $124.98
- Epclusa (Drug) $117.52
- Creon (Drug) $93.55
- ENTYVIO (Biological) $90.07
- Motegrity (Drug) $89.21
- Kristalose 20gm (Drug) $72.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fair Lawn
Dr. Ramesh Gupta, M.d, M.D
Gastroenterology — Payments: $170,465
Gastroenterology $170,465
Dr. Donald Kutner, Do, DO
Gastroenterology — Payments: $6,549
Gastroenterology $6,549
Jeffrey Lefkowitz, Md, MD
Gastroenterology — Payments: $5,449
Gastroenterology $5,449
Dr. Jonathan Resnick, Md, MD
Gastroenterology — Payments: $3,830
Gastroenterology $3,830
Youssef Botros
Gastroenterology — Payments: $2,817
Gastroenterology $2,817
Kuchipudi Bapineedu, Md, MD
Gastroenterology — Payments: $674.39
Gastroenterology $674.39